Literature DB >> 26165048

Assessment of depression and anxiety in patients with chronic liver disease.

Dušan Dj Popović, Djordje M Ćulafić, Darija B Kisić Tepavčević, Nada V Kovačević, Milan M Špuran, Srdjan P Djuranović, Ivana A Jovičić, Miodrag N Krstić, Mirjana D Perišić, Tatjana D Pekmezović.   

Abstract

BACKGROUND/AIM: In recent years mental health of patients including those with chronic liver disease (CLD), has become interesting because its disturbance leads to reduced quality of life, that is associated with worsening of clinical outcome, reduced compliance and increased mortality. The aim of the study was to determinate the frequency and severity of depression and frequency of anxiety in patients with CLD and to assess the contribution of selected socio-demographic, clinical and laboratory risk factors for depression and anxiety.
METHODS: In this cross-sectional study, we used the Hamilton depression rating scale (HDRS) and Hamilton anxiety rating scale (HARS) in patients with CLD.
RESULTS: The study included 54 male and 43 female patients. Depression was present in 62.9%, and anxiety in 13.4% of the patients. A higher HDRS was noted in the patients older than 50 years (p = 0.022) and unemployed patients (p = 0.043). The patients with at least one episode of gastrointestinal bleeding had a significantly higher frequency of anxiety than those without bleeding (p = 0.018). A higher HARS score was present in the women (p = 0.011), unemployed patients (p = 0.008) and those with non-alcoholic liver disease (p = 0.007). There was a significant correlation between the mean corpuscular volume (MCV) and the value of the HDRS score, and between serum potassium and sodium levels and HDRS score.
CONCLUSION: Age and the mean corpuscular volume have significant influence on the HDRS score while unemployment, gastrointestinal bleeding, serum potassium and serum sodium have predictive value for HARS score.

Entities:  

Mesh:

Year:  2015        PMID: 26165048     DOI: 10.2298/vsp130904007p

Source DB:  PubMed          Journal:  Vojnosanit Pregl        ISSN: 0042-8450            Impact factor:   0.168


  6 in total

Review 1.  Sociodemographic Risk Factors for Depression in Patients With Chronic Liver Disease.

Authors:  Lucia Rivera-Matos; Sarah Andrews; Sheila Eswaran
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-05-27

Review 2.  Depression and Chronic Liver Diseases: Are There Shared Underlying Mechanisms?

Authors:  Xiaoqin Huang; Xiaoyun Liu; Yongqiang Yu
Journal:  Front Mol Neurosci       Date:  2017-05-08       Impact factor: 5.639

3.  Anxiety and Its Influencing Factors in Patients With Drug-Induced Liver Injury.

Authors:  Yi-Hui Liu; Yan Guo; Hong Xu; Hui Feng; Dong-Ya Chen
Journal:  Front Psychol       Date:  2022-06-28

4.  Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis.

Authors:  Jen-Kuei Peng; Nilay Hepgul; Irene J Higginson; Wei Gao
Journal:  Palliat Med       Date:  2018-10-22       Impact factor: 4.762

5.  Protective Effects of Liu Wei Di Huang Wan on the Liver, Orbitofrontal Cortex Nissl Bodies, and Neurites in MSG+PH-Induced Liver Regeneration Rat Model.

Authors:  Bin-Bin Zhao; Qing-Hua Long; Chao-Yang Wang; Lin-Lin Chen; Guang-Jing Xie; Wen-Ji Bo; Bo Xu; Ze-Fei Li; Han-Min Li; Ping Wang
Journal:  Evid Based Complement Alternat Med       Date:  2018-08-27       Impact factor: 2.629

6.  Preventive Effects of Escitalopram Against Anxiety-Like Depressive Behaviors in Monosodium Glutamate-Teated Rats Subjected to Partial Hepatectomy.

Authors:  Bin-Bin Zhao; Lin-Lin Chen; Qing-Hua Long; Guang-Jing Xie; Bo Xu; Ze-Fei Li; Ping Wang; Hanmin Li
Journal:  Front Psychol       Date:  2019-11-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.